|
|
|
¥ÕªZ¤h......¬ü°ê»s³y
 
¬°¤°»ò¿ï¾Ü¥ÕªZ¤h¡H
 
1.
¥ÕªZ¤h²£«~ªº°t¤è¡A¬O®Ú¾Ú¦h¦WÀç¾i¸É¥R«~¡B§Ü°I¦Ñ©M¹B°ÊÀç¾iªºÅv«Â¤H¤hªº¬ã¨s¦Ó©w¥ßªº¡C
 
2.
©Ò¦³¥ÕªZ¤hªº²£«~¡A¬O¥Ñ¼Æ¶¡¬ü°êªº­¹«~»s³y°Ó©MÃļt­t³d¥Í²£ªº¡C¥¦­Ì¬O¸g¹L¥ÕªZ¤h¤d¬D¸U¿ï¡A¥þ³¡²Å¦X·í¦aÀu½è»s³yµ{§Ç¼Ð·Ç(GMP)¡C²£«~»s¦¨«á¡A¥ÕªZ¤h·|©â¨ú¼Ë¥»¡A¥æµ¹²Ä¤TªÌ¤ÆÅç©Ò´ú¸Õ¯Â«×©M¦Ã¬Vª«¡C
 
3.
¥ÕªZ¤h¥X«~ªº²Ä¤@´Ú²£«~¬O¼W­«Àç¾i¯»¡A·í®É¦Ü¤µ¬O°ß¤@§¹¥þ¤£§t¨Å¿}ªº¼W­«²£«~¡C¥Õ¤H¥@¥@¥N¥N¶¼¤û¥¤¡A¦]¦¹¦³³¡¤À¦¨¦~¥Õ¤H¯à°÷®ø¤Æ¨Å¿}¡C¨È¬w¤H«hµ´¤j¦h¼Æ¤£¯à®ø¤Æ¨Å¿}¡C«¢¦ò¤j¾Çªº§JªLº¿³Õ¤h(Dr Daniel Cramer) ªº¬ã¨sµo²{¡A¨Å¿}ùتº¤@ºØª«½ègalactose¡A¹ï¤k©Êªº§Z±_¦³®`¡A¥i­°§C¦¨¥¥²v¡C (¨Ó·½¡GCramer DW, et al. Amer J Epidemiol 1994, 139:282-89.)
 
4.
¥ÕªZ¤h²£«~µ´¤£§t¦³¤@¨Ç¤wª¾ªº¡B©Î³QÃhºÃªº¦³®`ª«½è¡A¦p¤H³y¥N¿}ªü¥q¤Ú²¢aspartame¡B¤H³y¥N¿}saccharin¡B¤H³y¦â¯À¡B¤H³y¨¾»G¾¯¡Bcarrageenan¡B°ò¦]§ï³y­¹ª«¡B¥Õ¬â¿}µ¥¡C¯ó¥»©M³½ªo²£«~ªº­«ª÷Äݧt¶q¦X²ÅÁp¦X°ê½Ã¥Í²Õ´(WHO)©Î¼w°êCommission Eªº¼Ð·Ç¡C
 
5.
¥ÕªZ¤h¤£·|¥Í²£¤@¨Ç¥¼³Q»{µý¬°¦³®Ä©M¦w¥þªº·s²£«~¡C
 
6.
¥ÕªZ¤h²£«~ªº«Å¶Ç¸ê®Æµ´¹ï¸Û¹ê¡B¤£¸Ø¤j¡C
 
 
Copyright © 2003 White Knight. All Rights Reserved.